HER2-overexpressing metastatic breast cancer: The role of trastuzumab regimens Journal Article

  

Authors:	Danso, M. A.; Seidman, A. D.
Article Title:	HER2-overexpressing metastatic breast cancer: The role of trastuzumab regimens
Keywords:	signal transduction; vasculotropin; clinical trial; drug tolerability; doxorubicin; cancer combination chemotherapy; drug efficacy; drug potentiation; monotherapy; nonhuman; treatment planning; drug approval; note; drug targeting; gemcitabine; paclitaxel; evidence based medicine; gene overexpression; carboplatin; metastasis; quality of life; breast cancer; bleeding; blood toxicity; epidermal growth factor receptor 2; febrile neutropenia; standard; cardiotoxicity; gefitinib; epirubicin; platinum derivative; taxane derivative; anthracycline derivative; trastuzumab; navelbine; vasculotropin antibody; liposome; drug formulation; canertinib; human
Journal Title:	Clinical Breast Cancer
Volume:	4
Issue:	5
ISSN:	1526-8209
Publisher:	Elsevier Inc.
Date Published:	2003-12-01
Start Page:	338
End Page:	339
Language:	English
PROVIDER:	scopus
DOI:	10.1016/S1526-8209(11)70946-6
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-0942298835&partnerID=40&md5=6e3a6b885c750cd00a32c074e9fc5ed4
Notes:	Export Date: 25 September 2014 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/60972